Although we did not evaluate the anti-influenza protective effect of recombinant LAIV/SARS-CoV-2 in mice in the current study because of the limited number of available animals, our previous results assume that NA- and NS-modified recombinant LAIVs can induce sterile immunity to influenza [22,23]. This evidence concerns the gene XK and influenza.